MONTVALE, N.J., Sept. 13 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that Jim Sulat, President and Chief Executive Officer, will provide a company update at the Maxim Group Growth Conference on Thursday, September 20, 2007 at 12:00 p.m. (EDT). The conference is being held at the Grand Hyatt Hotel in New York City.
Interested parties may access the live webcast of the presentation by visiting the “Investors” section of Memory Pharmaceuticals’ website at http://www.memorypharma.com. Archived versions of the webcast will be available at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249; or Laura Perry,Stern Investor Relations, Inc., +1-212-362-1200, both for MemoryPharmaceuticals Corp.
Web site: http://www.memorypharma.com/
